hepat
b
viru
hbv
caus
agent
chronic
hepat
b
chb
lead
liver
cirrhosi
hepatocellular
carcinoma
world
health
organ
report
million
peopl
worldwid
chronic
hbv
despit
effect
hbv
vaccin
worldwid
preval
diseas
remain
high
chb
major
global
health
problem
current
therapeut
regimen
chb
includ
pegyl
interferon
ifn
nucleosidenucleotid
analogu
treatment
aim
prevent
progress
diseas
liver
failur
cirrhosi
hepatocellular
carcinoma
howev
treatment
limit
effect
hbv
clearanc
fact
pegyl
ifn
maintain
viral
suppress
approxim
patient
nucleosid
nucleotid
analogu
inhibit
hbv
replic
target
viral
dna
polymeras
longterm
treatment
requir
achiev
clinic
benefit
exampl
cours
lamivudin
achiev
clearanc
hepat
b
e
antigen
hbeag
approxim
patient
chb
moreov
longterm
treatment
associ
higher
risk
side
effect
emerg
drug
resist
virus
result
treatment
failur
diseas
progress
therefor
vital
develop
new
type
antivir
drug
hepat
b
treatment
hbv
life
cycl
hepat
b
surfac
antigen
hbsag
initi
attach
heparan
sulfat
proteoglycan
host
cell
surfac
attach
seem
rel
low
affin
revers
essenti
subsequ
specif
interact
hb
hepatocytespecif
bile
acid
transport
sodium
taurochol
cotransport
polypeptid
ntcp
although
variou
membran
protein
report
hbv
entri
receptor
accumul
evid
suggest
ntcp
essenti
receptor
hbv
infect
discoveri
receptor
dramat
increas
understand
molecular
basi
hbv
entri
viral
entri
current
one
import
target
search
new
drug
treat
viral
infect
identif
ntcp
kindl
interest
explor
compound
inhibit
hbv
entri
ntcp
exclus
express
basolater
membran
hepatocyt
involv
reuptak
conjug
bile
acid
bloodstream
hepatocyt
ntcp
one
factor
highli
restrict
host
tropism
hbv
hepatocyt
specif
interact
domain
hbsag
ntcp
trigger
hbv
attach
initi
entri
hepatocyt
synthet
peptid
drug
myrcludex
b
exhibit
signific
antihbv
activ
competit
inhibit
interact
vitro
vivo
current
undergo
phase
ii
clinic
trial
chronic
hbvinfect
patient
physiolog
substrat
ntcp
taurochol
glycochol
acid
also
inhibit
hbv
infect
suggest
competit
bind
bile
acid
ntcp
interestingli
bind
could
trigger
type
ifn
signal
wherea
bile
acid
treatment
bile
acid
intak
via
ntcp
found
inhibit
ifn
pathway
physiolog
relev
rang
concentr
observ
support
possibl
ntcp
also
take
part
ifnmedi
innat
antivir
respons
high
express
often
caus
cell
cycl
inhibit
convent
hepatocellular
carcinoma
cell
line
ectop
express
high
level
ntcp
moreov
commerci
avail
monoclon
antibodi
mab
specif
recogn
cellsurfac
ntcp
due
difficulti
produc
fulllength
ntcp
protein
nativ
structur
current
studi
gener
hbvsuscept
cell
tetracyclineinduc
ntcp
gene
intcp
cell
without
affect
cell
growth
also
gener
high
qualiti
mab
clone
effici
detect
cellsurfac
ntcp
use
tool
identifi
compound
glabridin
significantli
inhibit
hbv
infect
downregul
ntcp
cell
surfac
endogen
ntcp
express
rare
detect
hepatoma
cell
line
cell
suscept
hbv
infect
therefor
gener
intcp
cell
line
cell
line
harbor
tetracyclineinduc
human
ntcp
gene
figur
treatment
intcp
cell
line
tetracyclin
analogu
doxycyclin
dox
caus
express
ntcp
doxdepend
manner
ntcp
express
higher
endogen
express
differenti
heparg
cell
primari
hepatocyt
reveal
western
blot
quantit
revers
transcriptionpcr
figur
determin
whether
doxinduc
ntcp
protein
local
plasma
membran
perform
peptid
bind
assay
found
peptid
detect
doxtreat
intcp
cell
untreat
cell
indic
presenc
ntcp
cell
surfac
figur
consist
previou
report
western
blot
ntcp
show
major
band
kd
shift
singl
band
kd
treatment
peptid
nglycosidas
pngase
impli
ntcp
modifi
nglycosyl
supplementari
figur
although
ntcp
express
report
affect
cell
prolifer
intcp
cell
show
differ
cell
cycl
progress
cell
expans
without
dox
treatment
figur
subsequ
examin
suscept
intcp
cell
hbv
infect
moi
geqcel
intcp
cell
show
high
suscept
hbv
infect
infect
without
dmso
treatment
figur
supplementari
figur
infect
significantli
inhibit
peptid
treatment
figur
indic
hbv
infect
ntcpmediat
taken
togeth
result
show
doxinduc
ntcp
protein
expos
cell
surfac
function
interact
although
result
suggest
ntcp
protein
local
cell
surfac
could
directli
demonstr
due
lack
suitabl
antibodi
flow
cytometri
immunofluoresc
microscopi
analysi
therefor
gener
monoclon
antibodi
mab
purpos
recombin
ntcp
protein
tend
form
insolubl
aggreg
util
wheat
germ
cellfre
system
shown
advantag
product
membran
protein
synthes
ntcp
protein
purifi
use
immun
mice
hybridoma
clone
establish
figur
use
flow
cytometerbas
screen
assay
doxtreat
untreat
intcp
cell
identifi
hybridoma
clone
produc
antintcp
mab
clone
figur
mab
could
recogn
endogen
ntcp
differenti
heparg
cell
supplementari
figur
perform
immunofluoresc
microscopi
use
mab
variou
cell
line
cellsurfac
ntcp
clearli
observ
figur
threedimension
organoid
cultur
recapitul
cellcel
interact
recent
studi
indic
advantag
hepatoma
organoid
hepat
viru
infect
investig
local
ntcp
hepatoma
organoid
embed
intcp
cell
hydrogel
perform
immunofluoresc
microscopi
mab
visual
ntcp
ntcp
local
widespread
membran
intern
cell
well
surfac
organoid
figur
epitop
map
use
recombin
ntcp
mutant
reveal
mab
recogn
amino
acid
ntcp
figur
test
whether
antibodi
inhibit
hbv
infect
pretreat
intcp
cell
primari
human
hepatocyt
mab
subsequ
infect
cell
wild
type
hbv
hbv
encod
luciferas
report
gene
hbvnl
mab
fail
inhibit
hbv
infect
figur
suggest
interact
mab
ntcp
neither
block
hbvhost
cell
interact
caus
downregul
ntcp
cell
surfac
mab
bind
ntcp
interfer
local
function
use
screen
antivir
compound
modul
level
cellsurfac
ntcp
briefli
intcp
cell
treat
differ
lowmolecularweight
chemic
compound
librari
deriv
natur
plant
extract
hour
subsequ
quantifi
cell
viabil
amount
cellsurfac
ntcp
use
mab
figur
identifi
two
compound
geraldol
glabridin
could
decreas
amount
cellsurfac
ntcp
without
observ
cytotox
figur
flow
cytometri
analysi
use
mab
demonstr
geraldol
glabridin
decreas
level
cellsurfac
ntcp
dosedepend
fashion
figur
analysi
reveal
geraldol
neg
regul
tetracyclinerespons
promot
activ
figur
microscal
thermophoresi
analysi
biomolecular
interact
reveal
glabridin
could
weakli
directli
interact
ntcp
figur
therefor
focus
glabridin
function
analys
flow
cytometri
analysi
show
glabridin
downregul
amount
cellsurfac
ntcp
heparg
cell
valu
respect
figur
notabl
treatment
glabridin
effect
level
ntcp
mrna
supplementari
figur
suggest
glabridin
affect
ntcp
protein
rather
ntcp
gene
express
consist
treatment
glabridin
rapidli
within
three
hour
modul
membran
local
ntcp
transferrin
receptor
figur
similar
result
obtain
cellsurfac
biotinyl
analysi
cellsurfac
protein
purifi
detect
western
blot
supplementari
figur
immunofluoresc
microscopi
use
mab
show
glabridintr
cell
ntcp
mainli
accumul
cytoplasm
figur
test
role
endocytosi
ntcp
local
treat
cell
concurr
glabridin
inhibitor
clathrinmedi
caveolar
endocytosi
found
genistein
specif
inhibitor
caveolar
endocytosi
complet
disrupt
ntcp
intern
figur
suggest
glabridin
caus
intern
ntcp
caveolar
endocytosi
intern
membran
protein
typic
traffick
degrad
recycl
pathway
next
perform
cycloheximid
chase
assay
interestingli
ntcp
protein
level
rel
stabl
control
cell
halflif
ntcp
significantli
shorter
glabridintr
cell
figur
suggest
glabridin
reduc
amount
ntcp
cell
surfac
promot
endocytosi
subsequ
intracellular
degrad
previou
report
indic
glabridin
induc
apoptosi
certain
cancer
cell
observ
neg
effect
cell
viabil
experiment
condit
figur
next
assess
impact
glabridin
hbv
infect
hepatocyt
timeofaddit
experi
demonstr
glabridin
inhibit
hbv
infect
ad
earli
infect
becam
less
effect
ad
later
figur
suggest
act
earli
stage
viral
life
cycl
inde
glabridin
ad
hbvproduc
cell
affect
amount
coreassoci
viral
dna
andor
rna
supplementari
figur
consist
observ
intcp
cell
treat
glabridin
three
hour
prior
infect
show
signific
reduct
percentag
infect
cell
amount
hbsag
secret
figur
perform
parallel
analysi
differenti
heparg
cell
confirm
glabridin
block
hbv
infect
downregul
endogen
ntcp
valu
figur
result
suggest
glabridin
inhibit
hbv
infect
remov
ntcp
cell
surfac
ntcp
transport
bile
acid
uptak
investig
effect
glabridin
ntcpmediat
uptak
taurochol
tca
sodiumcontain
condit
found
glabridin
reduc
tca
uptak
dose
timedepend
manner
figur
previou
studi
shown
ntcpmediat
bile
acid
transport
affect
express
ifn
stimulatori
gene
isg
primari
human
hepatocyt
investig
whether
glabridin
counteract
function
bile
acid
primari
human
hepatocyt
treat
type
ifn
tca
presenc
absenc
glabridin
treatment
ifn
upregul
variou
isg
protein
includ
known
inhibit
hbv
replic
concurr
treatment
tca
reduc
effect
figur
accord
previou
observ
interestingli
addit
glabridin
partial
cancel
effect
tca
isg
express
figur
find
suggest
glabridin
enhanc
innat
immun
respons
suppress
bile
acid
uptak
hepatocyt
downregul
cellsurfac
ntcp
studi
gener
intcp
cell
high
ntcp
express
high
suscept
hbv
infect
also
develop
monoclon
antibodi
mab
recogn
cellsurfac
ntcp
use
tool
identifi
glabridin
compound
inhibit
hbv
infect
downregul
level
entri
receptor
ntcp
although
primari
hepatocyt
express
ntcp
low
level
uptak
bile
acid
endogen
ntcp
hepatocellular
carcinoma
cell
line
suffici
achiev
success
infect
hbv
vitro
hepatocellular
carcinoma
cell
line
stabli
express
ntcp
creat
exhibit
increas
suscept
hbv
infect
shown
continu
ntcp
express
induc
cell
cycl
arrest
phase
indic
ectop
ntcp
express
may
unfavor
longterm
cultur
overcom
issu
creat
intcp
cell
line
featur
induc
ntcp
express
use
thirdgener
tetracyclineinduc
gene
express
system
cell
upon
transient
treatment
tetracyclin
deriv
cell
line
exhibit
high
express
cellsurfac
ntcp
becom
highli
suscept
hbv
infect
without
observ
cell
cycl
arrest
uniqu
featur
newli
develop
cell
line
make
use
tool
biolog
analysi
ntcp
hepat
cell
creat
new
mab
recogn
cellsurfac
ntcp
use
wheat
germ
cellfre
protein
product
system
synthes
fulllength
recombin
ntcp
protein
use
immun
mice
gener
qualiti
antibodi
determin
larg
antigen
use
immun
prepar
immunogen
deriv
highli
insolubl
membran
protein
challeng
ntcp
tend
insolubl
convent
cell
express
system
due
multipl
transmembran
domain
sever
method
prepar
antigen
deriv
insolubl
protein
includ
use
synthet
peptid
contain
predict
immunogen
epitop
extracellular
domain
synthet
peptid
structur
linear
recapitul
nativ
structur
featur
membran
protein
contrast
wheat
germ
cellfre
protein
product
system
util
eukaryot
translat
system
synthes
structur
intact
biolog
activ
protein
similar
express
mammalian
cell
approach
enabl
us
creat
mab
capabl
detect
spatial
antigen
within
region
ntcp
expos
cell
surfac
work
demonstr
advantag
cellfre
system
product
protein
multipl
transmembran
domain
threedimension
structur
ntcp
protein
well
character
number
transmembran
domain
controversi
present
sever
group
predict
ntcp
transmembran
domain
cterminu
ntcp
locat
cytoplasm
found
mab
recogn
amino
acid
ntcp
intact
cell
without
membran
permeabil
impli
epitop
possibl
expos
extracellular
space
precis
structur
biolog
studi
carri
elucid
topolog
ntcp
protein
immunofluoresc
microscopi
experi
use
antibodi
reveal
ntcp
local
plasma
membran
frequent
cellcel
contact
site
local
obviou
hepatocyt
organoid
cultur
system
suggest
local
ntcp
may
depend
cell
polar
threedimension
cultur
system
recapitul
cell
polar
use
analyz
function
ntcp
sodium
taurochol
transport
well
hbv
infect
recent
studi
demonstr
threedimension
cultur
system
suitabl
analyz
polar
hbv
transmiss
well
establish
whether
ntcp
play
role
viral
transmiss
polar
cell
newli
develop
mab
may
use
pursu
intrigu
question
sever
compound
shown
target
ntcp
recent
studi
demonstr
antagonist
retino
acid
receptor
cytokin
could
reduc
ntcp
express
previou
report
also
indic
green
tea
extract
egcg
also
inhibit
hbv
entri
primari
human
hepatocyt
interestingli
egcg
induc
endocytosi
ntcp
plasma
membran
follow
protein
degrad
current
studi
found
glabridin
compound
licoric
extract
also
caus
ntcp
receptor
downregul
although
precis
mechan
unclear
find
suggest
glabridin
directli
bind
ntcp
caus
intern
caveolar
endocytosi
estim
protein
turnov
use
cycloheximid
chase
assay
abl
infer
glabridin
promot
intracellular
degrad
ntcp
interestingli
glabridin
oral
bioavail
known
rapidli
accumul
liver
sinc
valu
glabridin
inhibit
hbv
entri
rel
high
compound
might
littl
translat
benefit
hbv
research
howev
data
obtain
studi
demonstr
potenti
scope
current
methodolog
drug
discoveri
hbv
therapeut
possibl
intern
ntcp
could
inhibit
transport
activ
therebi
caus
unfavor
effect
hepatocyt
howev
peopl
mutat
ntcp
gene
show
decreas
surfac
express
transport
activ
ntcp
report
seriou
diseas
result
mutat
date
frequent
occurr
physiolog
downregul
ntcp
also
notabl
downregul
typic
control
transcript
factor
cholestasi
condit
furthermor
recent
paper
shown
ntcp
main
transport
conjug
bile
acid
liver
auxiliari
transport
oatp
may
compens
ntcp
absent
although
report
hint
transient
downregul
ntcp
might
induc
immedi
advers
effect
liver
effect
investig
vivo
model
determin
whether
ntcp
inhibit
reason
antihbv
drug
target
conclus
identifi
glabridin
natur
compound
capabl
inhibit
hbv
infect
impair
viral
entri
host
cell
addit
effect
enhanc
antivir
immun
respons
furthermor
data
demonstr
newli
develop
cell
line
antibodi
serv
power
tool
drug
discoveri
target
hbv
entri
explor
molecular
mechan
underli
hbv
spread
gener
intcp
cell
teton
advanc
cell
clontech
parent
cell
line
transduc
retrovir
vector
encod
ntcp
gene
fuse
tetracyclinerespons
element
select
puromycin
cultur
dmem
wako
supplement
fb
unless
otherwis
indic
intcp
cell
treat
doxycyclin
sigmaaldrich
hour
experi
intcp
spheroid
made
use
life
dextrancd
hydrogel
sg
kit
cellend
cultur
seven
day
chamber
slide
thermo
fisher
scientif
primari
human
hepatocyt
pxbcell
purchas
phoenixbio
heparg
cell
purchas
biopred
intern
differenti
accord
manufactur
instruct
chemic
compound
librari
natur
plant
extract
obtain
tokiwa
phytochem
nocodazol
cyclosporin
genistein
purchas
sigmaaldrich
glabridin
staurosporin
obtain
wako
protemist
xe
robot
protein
synthes
cellfre
scienc
use
gener
full
length
ntcp
truncat
deriv
previous
describ
immun
balbc
mice
recombin
ntcp
gener
hybridoma
cell
produc
antintcp
antibodi
perform
previous
describ
purif
antibodi
cultur
supernat
hybridoma
clone
perform
centrifug
rpm
minut
elut
acrosep
hyper
df
column
pall
sampl
concentr
use
amicon
ultra
filter
merck
millipor
immunoglobulin
character
carri
use
isostrip
mous
monoclon
antibodi
isotyp
kit
roch
cell
fix
paraformaldehyd
block
normal
goat
serum
thermo
fisher
scientif
stain
either
antintcp
mab
clone
antihbcag
polyclon
antibodi
dako
alexa
fluorconjug
secondari
antibodi
thermo
fisher
scientif
alexa
fluor
phalloidin
thermo
fisher
scientif
use
factin
stain
intracellular
stain
cell
permeabil
triton
block
bind
assay
intcp
cell
pretreat
dox
hour
incub
nm
fitcconjug
peptid
first
amino
acid
residu
small
hb
domain
fuse
ntermin
myristoyl
group
ctermin
fitc
c
two
hour
cell
wash
pb
fix
paraformaldehyd
microscop
imag
perform
confoc
laser
scan
microscop
olympu
fluoresc
microscop
keyenc
cell
detach
mm
edta
pb
fix
formaldehyd
incub
either
antintcp
antitransferrin
receptor
genetex
antibodi
c
cell
stain
peconjug
secondari
antibodi
analyz
use
facscanto
ii
instrument
bd
bioscienc
drug
screen
cell
treat
candid
compound
hour
analysi
data
analyz
flowjo
softwar
treestar
wildtyp
hbv
deriv
supernat
cell
stabli
transfect
complet
hbv
genom
hbv
report
virus
hbvnl
produc
transient
transfect
cell
puchbvd
previous
describ
collect
supernat
filter
filter
merck
millipor
concentr
approxim
time
use
peg
viru
precipit
kit
biovis
cell
infect
wildtyp
hbv
concentr
genom
equival
per
cell
presenc
hour
altern
cell
plate
inocul
hbvnl
presenc
hour
hbvinfect
cell
cultur
fresh
medium
addit
day
infect
determin
intracellular
hbcag
stain
extracellular
hbsag
quantif
previous
describ
infect
hbvnl
quantifi
use
nanoglo
luciferas
system
promega
accord
manufactur
instruct
sampl
sd
load
buffer
load
onto
polyacrylamid
gel
electrophores
blot
onto
pvdf
membran
merck
millipor
previous
describ
membran
probe
primari
antibodi
horseradish
peroxidaseconjug
secondari
antibodi
ge
healthcar
protein
degrad
analysi
cycloheximid
ad
hour
harvest
cell
primari
antibodi
use
follow
antintcp
antivinculin
sigmaaldrich
antihi
genetex
detect
protein
visual
use
fluorchem
digit
imag
system
alpha
innotech
band
analysi
perform
imagej
softwar
nation
institut
health
messeng
rna
extract
subsequ
cdna
synthesi
perform
use
trizol
reagent
thermo
fisher
scientif
revertra
ace
toyobo
respect
accord
manufactur
instruct
gene
express
analyz
qpcr
use
sybr
premix
ex
taq
ii
takara
realtim
pcr
detect
system
biorad
primer
pair
use
actb
ntcp
recombin
ntcpgfp
gfp
protein
incub
differ
concentr
compound
mm
potassium
phosphat
buffer
ph
contain
mm
nacl
bsa
ddm
one
hour
room
temperatur
sampl
load
monolith
standard
treat
capillari
nano
temper
technolog
analyz
monolith
blue
red
microscal
thermophoresi
instrument
cell
cycl
analysi
perform
tali
imagebas
cytomet
thermo
fisher
scientif
cell
viabil
measur
cell
count
dojindo
celltiterglo
assay
promega
accord
manufactur
instruct
cell
treat
taurochol
acid
tca
sodiumfre
sodiumcontain
buffer
minut
allow
tca
uptak
cell
cell
wash
intracellular
radioact
measur
use
liquid
scintil
counter
graph
repres
mean
standard
deviat
statist
signific
differ
two
group
test
use
twotail
unpair
test
prism
softwar
graphpad
